Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nitroindazole extended release - Beyond Air

Next Previous
X
Search
Drug Profile

Nitroindazole extended release - Beyond Air

Alternative Names: 7-NI; 7-nitroindazole; Neuronal nitric oxide synthase inhibitor - Beyond Air; nNOS inhibitor - Beyond Air

Latest Information Update: 20 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hebrew University of Jerusalem
  • Developer Beyond Air
  • Class Anti-inflammatories; Antiepileptic drugs; Behavioural disorder therapies; Neuroprotectants; Nitro compounds; Small molecules
  • Mechanism of Action Nitric oxide synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Autistic disorder

Most Recent Events

  • 18 Sep 2023 Pharmacodynamic and pharmacokinetics data from preclinical studies in Autism disorder released by Beyond Air
  • 07 Aug 2023 Pharmacodynamics data from a preclinical studies in Autism disorder released by Beyond Air
  • 15 Jun 2023 Beyond Air in-licenses nitric oxide synthase inhibitors from Hebrew University of Jerusalem

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top